Daisuke Kaneda
2PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Jun 21, 2022
The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity.Daisuke Kaneda, Tomoko Iehara, Ken Kikuchi
|Aug 28, 2020
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA.Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara
Pageof 1
